Michaela Lantz

Michaela Lantz is a Principal Scientist I at AbbVie, focusing on biologics drug product development. They earned a Ph.D. in Pharmaceutical Chemistry from The University of Kansas, where their research involved the genetic engineering and purification of a novel protein tag. Prior to their current role, Michaela held positions at Sanofi and Array BioPharma, contributing to drug product development and modified release technologies. They also obtained a Master’s Degree in Pharmaceutical Chemistry from The University of Kansas and a Bachelor of Science in Chemical and Biochemical Engineering from the Colorado School of Mines.